Manuel Colucci
Lugano, TI, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Electrophilic compound screening identifies GPX4-dependent ferroptosis as a senescence vulnerability.
Journal: Nature cell biology
Published: September 10, 2025
Myeloid-derived suppressor cells promote therapy-induced resistance in prostate cancer.
Journal: International journal of surgery (London, England)
Published: July 16, 2025
Carcinogenic health outcomes associated with endocrine disrupting chemicals exposure in humans: A wide-scope analysis.
Journal: Journal of hazardous materials
Published: March 21, 2024
Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer.
Journal: Cancer cell
Published: December 06, 2023
Author Correction: Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer.
Journal: Nature communications
Published: July 20, 2023
The mixed effect of Endocrine-Disrupting chemicals on biological age Acceleration: Unveiling the mechanism and potential intervention target.
Journal: Environment international
Published: June 20, 2023
The potential role of the microbiota in prostate cancer pathogenesis and treatment.
Journal: Nature reviews. Urology
Published: June 15, 2023
Targeting senescence induced by age or chemotherapy with a polyphenol-rich natural extract improves longevity and healthspan in mice.
Journal: Nature aging
Published: June 11, 2023
VSSP-activated macrophages mediate senescence and tumor inhibition in a preclinical model of advanced prostate cancer.
Journal: Cell communication and signaling : CCS
Published: November 18, 2022
Last Updated: 09/26/2026